Newsletter | September 10, 2020

09.10.20 -- Oncology Biosimilars: Prepare For A Non-Buy & Bill World

 
Sponsor
Featured Editorial
Industry Insights
Is Your Sterile Injectable Ready For Changes In Raw Materials?

Over the life of a drug, changes in raw materials are inevitable. But even a small modification can throw your drug out of compliance. Learn how to safeguard drug integrity when raw materials change.

Sponsor Challenges When Outsourcing Sterile Injectables

ISR asked outsourcers of sterile injectable drug product to identify their biggest challenge when outsourcing to CDMOs/CMOs. Here's a look at the resulting nearly four-way tie.

Effects Of Feeding Strategy On CHO Cell Performance In Fed-Batch Cultures

This article demonstrates a fed-batch process for a CHO cell line producing a mAb. The results emphasize the importance of an appropriate feeding strategy to optimize cell growth and productivity.

News Headlines
Solutions